#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Dermatitis atopic Asthma Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Mantle cell lymphoma stage IV Aplastic anaemia Crohn's disease Extra-osseous Ewing's sarcoma metastatic Alexander disease Subarachnoid haemorrhage Mantle cell lymphoma recurrent Multiple system atrophy Breast angiosarcoma metastatic Cutaneous T-cell lymphoma refractory C3 glomerulopathy Ornithine transcarbamoylase deficiency Follicular lymphoma stage II B-cell type acute leukaemia Anal cancer recurrent More trials…

    Learn about Rare Diseases

    Waldenstrom’s macroglobulinaemia refractory – Diagnostics Sarcoma – Treatment Bronchiolitis obliterans syndrome – Diagnostics Chondrosarcoma – Life with Disease Niemann-Pick disease Haemolytic uraemic syndrome – Treatment Encephalitis autoimmune Haemophilia A with anti factor VIII – Basic Information Chronic granulomatous disease – Life with Disease Myelodysplastic syndrome with excess blasts – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Buloxibutid Phleum Pratense (225) A49 Dfv890 Efavirenz Reparixin Tipiracil Omeprazole Zinc Oxide Bi 764524 Netupitant GSKVX000000070248 Zanidatamab Dazostinag Duloxetine Alx148 Lenacapavir Sodium Db-Oto-3 Folinic Acid Azelastine More therapies…

    Learn about Your Condition

    Gout Polycystic liver disease Alcoholism Primary amyloidosis Pustular psoriasis Liposarcoma metastatic Pneumococcal infection Mucopolysaccharidosis III Still's disease Hidradenitis Uveal melanoma Primary myelofibrosis Agitation postoperative Lichenoid keratosis Ankylosing spondylitis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Institut Paoli-Calmettes Cancer Centre

Institut Paoli-Calmettes Cancer Centre

2eo Bfxrjxjlm Du Sgrudu Mknkaipytps Bc 1wst Mwyhwbqjux 1gmdjv Fxnfkl

Want to learn more about this study or check if you can participate? Contact us.

  • Study Comparing Gilteritinib and Midostaurin with Chemotherapy for Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome with FLT3 Mutation

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Gilteritinib
    • Midostaurin
    Austria Belgium Finland France Germany Ireland +5

  • Study on Dostarlimab, Vitamin D3, and Drug Combination for Untreated Metastatic Pancreatic Cancer Patients

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Pancreatic carcinoma
    • Pancreatic carcinoma metastatic
    Investigated Drugs:
    • Dostarlimab
    • Colecalciferol
    • Fluorouracil
    France

  • Study on the Effectiveness of Ivosidenib in Patients with IDH1 Mutated Myelodysplastic Syndrome

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Azacitidine
    • Ivosidenib
    France

  • Study Comparing Sentinel Node Policy with Current Staging Protocols in Early Stage Endometrial Cancer Using Patent Blue, Technetium (99mTc) Rheniumsulfide, and Indocyanine Green

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Human Albumin Solution
    • Indocyanine Green
    France

  • Study on Zoledronic Acid for Treating Osteosarcoma in Children, Adolescents, and Adults

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Zoledronic Acid Monohydrate
    France

  • Study on Cefoxitin and Sodium Chloride for Preventing Infections After Colorectal Surgery

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Post procedural infection
    Investigated Drugs:
    • Cefoxitin Sodium
    • Sodium Chloride
    France

  • Study of Sacituzumab Govitecan compared to standard therapy in HER2-negative breast cancer patients with high risk of relapse after neoadjuvant treatment

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Breast cancer recurrent
    • Breast cancer stage I
    • Breast cancer
    Investigated Drugs:
    • Capecitabine
    • Carboplatin
    • Cisplatin
    Austria Belgium France Germany Ireland Spain

  • Study of Itolizumab with Corticosteroids for Initial Treatment of Acute Graft Versus Host Disease in Patients After Bone Marrow Transplant

    Not recruiting

    3 1
    Investigated Diseases:
    • Allogenic stem cell transplantation
    • Graft versus host disease
    Investigated Drugs:
    • Itolizumab
    Belgium France Germany Italy Portugal Spain

  • Study on the Effectiveness of Lenvatinib for Patients with Advanced Gastrointestinal Stromal Tumors After Imatinib and Sunitinib Treatment Failure

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Gastrointestinal stromal tumour
    Investigated Drugs:
    • Lenvatinib
    France

  • Study Comparing Chemotherapy with Paclitaxel, Ifosfamide, and Cisplatin versus High-Dose Chemotherapy with Paclitaxel and Drug Combination for Relapsed Germ Cell Tumors

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Testicular germ cell cancer
    Investigated Drugs:
    • Ifosfamide
    • Carboplatin
    • Cisplatin
    Belgium Denmark France Germany Ireland Italy +2
Previous Page
1 … 25 26 27 28 29 … 42
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!